How to Buy Madrigal Pharmaceuticals Stock

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.

Madrigal Pharmaceuticals stock last closed at $432.22, down 1.65% from the previous day, and has increased 84.11% in one year. It has overperformed other stocks in the Biotechnology industry by 1.33 percentage points. Madrigal Pharmaceuticals stock is currently +115.43% from its 52-week low of $200.63, and -5.46% from its 52-week high of $457.16.

As of Sep 12, 2025, there are 22.29M MDGL shares outstanding. The market value of MDGL is $9.63B. In the last 24 hours, 191,000 MDGL shares were traded.

How to Buy Madrigal Pharmaceuticals Stock

Not sure how to invest in Madrigal Pharmaceuticals stock? Here's how.

  1. Choose where to buy Madrigal Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Madrigal Pharmaceuticals stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit money your brokerage account: Pick your payment method and add your details.
  4. Research Madrigal Pharmaceuticals stock: The Madrigal Pharmaceuticals ticker symbol is MDGL. Is Madrigal Pharmaceuticals stock a good investment? Should you buy shares of MDGL? How do MDGL's underlying business fundamentals look? Do top analysts think Madrigal Pharmaceuticals is a good buy? Why has MDGL's stock price moved recently? (Hint: Our stock analysis website can help you decide if MDGL is a good stock to buy).
  5. Make your MDGL purchase: Decide if you will purchase MDGL shares at the current market price or use a limit order to buy MDGL stock at a given price.
  6. Get key alerts regarding your MDGL investment: Create a watchlist to get live updates on your position in Madrigal Pharmaceuticals stock.

Step 1: Choose where to buy Madrigal Pharmaceuticals stock

You will need a brokerage account in order to access the NASDAQ market and buy MDGL shares.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in MDGL stock today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start your new trading account.
  1. Submit your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you've filled out your info on app for stock, your next step is to transfer the money for your investment:

Check out the tutorial below to see the process of depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Madrigal Pharmaceuticals stock

Once you have chosen the best place to buy Madrigal Pharmaceuticals stock, it's crucial to research their stock prior to buying, so you truly understand the risk as well as the opportunity.

Madrigal Pharmaceuticals quick stats

MDGL Price
$432.22
1w %
-0.15%
1y %
84.11%
5y %
303.72%
P/E
-33.95x
P/B
13.84x
P/S
18.62x
PEG
N/A
Revenue
$515.55M
Earnings
-$281.90M
Fore. Rev. Growth
52.6%
Fore. Earn. Growth
N/A
Market Cap
$9.63B
Next Earnings
Oct 29, 2025
Next Dividend
N/A

Madrigal Pharmaceuticals Overview

WallStreetZen was designed to help average investors do more accurate fundamental analysis quickly.

You can view all of the due diligence checks on MDGL's stock page.

How is MDGL stock valued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge MDGL's intrinsic value.

Using relative valuations methods:

  • MDGL may be overvalued based on its P/B ratio of 13.84x, relative to Biotechnology industry P/B ratio of 4.65x

You can access additional valuation research on MDGL's stock here.

A quick look at MDGL Financials

Signs that MDGL is financially healthy:

  • There are more short-term assets than short-term liabilities on the MDGL balance sheet.
  • MDGL has cash burn of 308387000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the MDGL balance sheet.
  • MDGL has $802.02M in cash and short term investments. This is enough to cover its annual cash burn of $308.39M.

Signs that MDGL is not financially healthy:

  • MDGL has a relatively high debt to equity ratio of 0.46.
  • MDGL profit margin has gone up by 34.32 percentage points in the past year, but the company is still unprofitable.
  • Total MDGL debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Madrigal Pharmaceuticals stock, according to Wall Street analysts?

Out of 6 Wall Street analysts who track MDGL, the consensus analyst rating on Madrigal Pharmaceuticals is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they financial advice.

Most Recent MDGL Analyst Upgrades/Downgrades

Mayank Mamtani, a top 4% analyst from B. Riley Securities reiterates MDGL with a strong buy rating and raises their MDGL price target from $422.00 to $460.00, on May 2, 2025.

B. Riley Securities's Mayank Mamtani raised their price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) by 9% from $422 to $460 on 2025/05/02. The analyst reiterated their Strong Buy rating on the stock.

Madrigal Pharmaceuticals reported its Q1 2025 earnings.

Hiking their price target, Mamtani highlighted that the quarter indicated strong Rezdiffra U.S. sales trends.

The analyst recommended buying the stock on any "sell-the-news" weakness.

You can dive deeper into what analysts are saying on the Madrigal Pharmaceuticals stock forecast page.

MDGL Technicals

SMA10
437.76
SMA20
421.56
SMA50
361.33
SMA100
327.4
SMA200
325.31
MACD
23.61
MACD Signal
26.44
MACD Histogram
-2.84
RSI
62.68
Stochastic %K
57.15
Stochastic %D
69.81
StochRSI %K
5.85
StochRSI %D
25.75

Is MDGL Growing Revenue?

Last year, MDGL revenue was $515.55M. Over the past one years, MDGL's revenue has grown by 3,421.98% per year. This was faster than the Biotechnology industry average of 66.52%.

Learn more about MDGL's earnings and revenue performance here.

What are MDGL executives and large shareholders up to?

Over the last 12 months, insiders at MDGL have bought more shares than they have sold.

William John Sibold, President and CEO of MDGL, was the latest MDGL insider to sell. They sold $3,243,740.77 worth of MDGL shares on Sep 9, 2025.

Learn more about who owns MDGL shares here.

Can I get consistent income from MDGL stock?

No, Madrigal Pharmaceuticals doesn't provide an income stream by paying out dividends.

MDGL Social Trading Data

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your MDGL purchase

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a given price, use a limit order.

Click the Open button and your broker will place the order.

If you require more assistance buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get key alerts regarding your MDGL investment

Now that you own some shares in MDGL, you'll want to keep up with your new stock purchase.

Start a watchlist to see the latest developments about your MDGL stock.

MDGL Feed

How to Buy Stock in Madrigal Pharmaceuticals

To summarize, here are the 6 steps to buy stock in Madrigal Pharmaceuticals:

  1. Choose where to buy Madrigal Pharmaceuticals stock
  2. Sign up for a brokerage account
  3. Deposit money your brokerage account
  4. Research Madrigal Pharmaceuticals stock
  5. Make your MDGL purchase
  6. Get key alerts regarding your MDGL investment

If you require a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get updates on your investment in Madrigal Pharmaceuticals, add MDGL to your watchlist below.

NASDAQ: MDGL
$432.22-7.23 (-1.65%)
Updated Sep 12, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: MDGL
$432.22-7.23 (-1.65%)
Updated Sep 12, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Madrigal Pharmaceuticals share?

As of Sep 12, 2025, it costs $432.22 to buy one share of Madrigal Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.231 shares of MDGL.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Madrigal Pharmaceuticals stock?

According to 6 Wall Street analysts who monitor Madrigal Pharmaceuticals, their consensus recommendation is to buy Madrigal Pharmaceuticals stock.

What is the best way to buy Madrigal Pharmaceuticals stock?

One way to place an order for Madrigal Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.